SFG
Stonebridge Financial Group Portfolio holdings
AUM
$1.03B
This Quarter Return
+0.78%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$907M
AUM Growth
–
Cap. Flow
+$907M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
33.12%
Holding
834
New
831
Increased
–
Reduced
–
Closed
–
Top Buys
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 9.03% |
| 2 | Financials | 5.38% |
| 3 | Healthcare | 3.94% |
| 4 | Industrials | 3.19% |
| 5 | Consumer Staples | 2.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Agnico Eagle Mines
AEM
$76.3B
| $15.6K | ﹤0.01% |
+200
| New | +$15.6K |
|
|
VRNA
527
Verona Pharma
VRNA
$9.2B
| $15.6K | ﹤0.01% |
+336
| New | +$15.6K |
|
528
Pentair
PNR
$18.1B
| $15.6K | ﹤0.01% |
+155
| New | +$15.6K |
|
529
Generac Holdings
GNRC
$10.6B
| $15.5K | ﹤0.01% |
+100
| New | +$15.5K |
|
530
Mid-America Apartment Communities
MAA
$17B
| $15.5K | ﹤0.01% |
+100
| New | +$15.5K |
|
531
Kyndryl
KD
$7.57B
| $15.4K | ﹤0.01% |
+446
| New | +$15.4K |
|
532
Inseego
INSG
$199M
| $15.4K | ﹤0.01% |
+1,500
| New | +$15.4K |
|
533
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.42B
| $15.3K | ﹤0.01% |
+216
| New | +$15.3K |
|
534
Xcel Energy
XEL
$43B
| $15.3K | ﹤0.01% |
+226
| New | +$15.3K |
|
535
McCormick & Company Non-Voting
MKC
$19B
| $15.3K | ﹤0.01% |
+200
| New | +$15.3K |
|
536
Digital Realty Trust
DLR
$55.7B
| $15.1K | ﹤0.01% |
+85
| New | +$15.1K |
|
537
Citigroup
C
$176B
| $15K | ﹤0.01% |
+213
| New | +$15K |
|
538
Globus Medical
GMED
$8.18B
| $14.9K | ﹤0.01% |
+180
| New | +$14.9K |
|
539
Univest Financial
UVSP
$898M
| $14.8K | ﹤0.01% |
+500
| New | +$14.8K |
|
540
Hewlett Packard
HPE
$31B
| $14.7K | ﹤0.01% |
+690
| New | +$14.7K |
|
541
Cadence Design Systems
CDNS
$95.6B
| $14.7K | ﹤0.01% |
+49
| New | +$14.7K |
|
542
Bit Digital
BTBT
$807M
| $14.7K | ﹤0.01% |
+5,000
| New | +$14.7K |
|
543
Intensity Therapeutics
INTS
$13.3M
| $14.6K | ﹤0.01% |
+8,301
| New | +$14.6K |
|
544
Pinduoduo
PDD
$177B
| $14.5K | ﹤0.01% |
+150
| New | +$14.5K |
|
545
Idexx Laboratories
IDXX
$51.4B
| $14.5K | ﹤0.01% |
+35
| New | +$14.5K |
|
546
Novartis
NVS
$251B
| $14.2K | ﹤0.01% |
+146
| New | +$14.2K |
|
547
Nuveen NASDAQ 100 Dynamic Overwrite Fund
QQQX
$1.33B
| $14.2K | ﹤0.01% |
+525
| New | +$14.2K |
|
548
Core Scientific
CORZ
$4.16B
| $14.1K | ﹤0.01% |
+1,000
| New | +$14.1K |
|
549
GSK
GSK
$81.6B
| $14K | ﹤0.01% |
+413
| New | +$14K |
|
550
Global Partners
GLP
$1.74B
| $14K | ﹤0.01% |
+300
| New | +$14K |
|